In an attempt to reduce the number of stillbirth, scientists claimed to have developed the world's first blood test that will aid in monitoring a fetus and determining the chances of stillbirth.
The test, which was developed Mercy Health researchers Clare Whitehead, Stephen Tong and Susan Walker, measures a baby's oxygen levels inside the womb, and could be more effective than an ultrasound, News.com.au reported.
Whitehead said that if they know how much oxygen the baby is getting they can deliver pregnancies prior to the oxygen levels becoming very low and the baby succumbing to stillbirths.
An international clinical trial is taking place across seven hospitals in Australia and New Zealand.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app